EFFECT OF P-GLYCOPROTEIN EXPRESSION ON OUTCOME IN THE EWING FAMILY OF TUMORS

References

• Horowitz ME, Malawer MM, Wo SY, Hicks MJ. Ewing sarcoma family of tumors: Ewing sarcoma of bone and soft tissue and the peripheral primitive neuroectodermal tumors. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. Philadelphia: Lippincott—Raven; 1997:831–857.
   Google Scholar
• Zucker JM, Henry-Amar M, Sarrazin D, Blache R, Patte C, Schwesguth 0. Intensive systemic chemotherapy in localized Ewing sarcoma in childhood: a historical trial. Cancer. 1983;52: 415–423.
   Google Scholar
• Kissane JM, Askin FB, Foulkes M, Stratton LB, Faulkner SS. Ewing sarcoma of bone: clinic opathologic aspects of 308 cases from the Intergroup Ewing Sarcoma Study. Hum Pathol. 1983;14: 773–779.
   Google Scholar
• Hayes FA, Thompson EL, Meyer WH, et al. Therapy for localized Ewing sarcoma of bone. J Clin Oncol 1989;7:208–213.
   PubMed Web of Science ®Google Scholar
• Bacci G, Toni A, Avella M, et al. Long-term results in 144 localized Ewing sarcoma patients treated with combined therapy. Cancer. 1989;63:1477–1486.
   PubMed Web of Science ®Google Scholar
• Juliano RL, Ling VA. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta. 1976;455:152–162.
   PubMed Web of Science ®Google Scholar
• Arceci RJ. Clinical significance of P-glyco protein in multidrug resistance malignancies. Blood. 1993;81: 2215–2222.
   PubMed Web of Science ®Google Scholar
• Hayes JD, Wolf CR. Molecular mechanisms of drug resistance-review. Biochem j 1990;272:281–295.
   PubMed Web of Science ®Google Scholar
• Pastan I, Gottesman M. Multiple-drug resistance in human cancer. N Engl J Med. 1987;316:1388–1393.
   PubMed Web of Science ®Google Scholar
• Ford JM, Hait WN. Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol Rea 1990;42:155–199.
   PubMed Web of Science ®Google Scholar
• Chan HS, Thorner PS, Haddad G, DeBoer G, Ling V. Multidrug resistance in sarcomas of children. In: Novak JF, McMaster JH, eds. Frontiers of Osteosarcoma Research. Seattle, WA: Hogrefe 8c Huber; 1993:51–60.
   Google Scholar
• Chan HS, Thorner PS, Haddad G, Ling V. Immunohistochemical detection of P-glycoprotein: prog-nostic correlation in soft tissue sarcoma of childhood. J Clin Oncol. 1990;8:689–704.
   PubMed Web of Science ®Google Scholar
• Lee JL, Hughes CS, Fine RL, Page RL. P-Glycoprotein expression in canine lymphoma. Cancer. 1996;77:1892–1898.
   PubMed Web of Science ®Google Scholar
• Yang X, Page M. P-Glycoprotein expression in ovarian cancer cell line following treatment with cisplatin. Oncol Res. 1995;7:619–624.
   PubMed Web of Science ®Google Scholar
• Obana K, Hashizume K, Tsuchida y et al. Expression of multidrug resistance-related P-glycoprotein in neuroblastoma cells. Int J Pediatr Hematol Oncol. 1995;1:565–569.
   Google Scholar
• Pu YS, Tsai TC, Cheng AL, et al. Expression of MDR-1 gene in transitional cell carcinoma and its correlation with chemotherapy response. J Urol 1996;156:271–275.
   PubMed Web of Science ®Google Scholar
• Roessner A, Ueda y Bockhorn-Dworniczak B, et al. Prognostic implication of immunodetection of P-glyco protein in Ewing sarcoma. J Cancer Res Chn Oncol. 1993;119:185–189.
   Google Scholar
• Hijazi YM, Axiotis C, Navarro S, Steinberg SM, Horowitz ME, Tsokos M. Immunohistochemical detec-tion of P-glycoprotein in Ewing's sarcoma and peripheral primitive neuroectodermal tumors before and after chemotherapy. Am J Clin Pathol. 1994;102:61–67.
   PubMedGoogle Scholar
• Axiotis C, Hijazi Y Jefferson J, Tsokos M. Expression of P-glycoprotein in small round cell tumors of childhood. Lab Invest. 1991;64:1P.
   Google Scholar
• Stein U, Shoemaker RH. Schlag PM. MDR 1 gene expression: evaluation of its use as a molecular marker for prognosis and chemotherapy of bone and soft tissue sarcomas. Eurf Cancer. 1996;32A:86–92.
   Google Scholar
• Fojo AT, Ueda K Salmon DJ, Po plack DG, Gottesman MM, Pastan I. Expression of multidrug-resistant gene in human tumors and tissues. Proc Natl Acad Sci USA. 1987;84:265–269.
   PubMed Web of Science ®Google Scholar
• Noona KF, Beck C, Holzmayer TA, et al. Quantitative analysis of MDR-1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA. 1990;87:7160–7164.
   Google Scholar
• Leuschner I, Schmidt D, Hoffman H, Dietel M, Harms D. Expression of P-glycoprotein in soft tissue tumors of childhood. Correlation of treatment response. J Cancer Res Chn Oncol 1991:117 97.
   Google Scholar
• Vergier B, C any L, Bonnet F, Rober J, De Masc arel A, Coindre JM. Expression of MDR-1/P-glycoprotein in human sarcomas. Br J Cancer. 1993;68:1221–1226.
   Google Scholar
• Stein U, Wunderlich V, Haensch W, Schmidt-Peter P. Expression of the MDR-1 gene in bone and soft tissue sarcomas of adult patients. Eur J Cancer. 1993;29A:1979–1981.
   Google Scholar
• Fogel M. Lifschitz-Mercer B, Moll R, et al. Heterogeneity of intermediate filament expression in human testicular seminomas. Differentiation 1990;45:242–249.
   Google Scholar
• Cattoretti G, Pileri S, Parravicini C, Becker MHG, Poggi S, Bifulco C. Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J Patho/. 1993;171:83–98.
   PubMed Web of Science ®Google Scholar
• Dixon WJ (chief editor). BMDP Statistical Software. Los Angeles, CA: University of California; 1990.
   Google Scholar
• Martinez A, San-Miguel JF, Valverde B, et al. Functional expression of MDR-1 in acute myeloid leukemia: correlation with the clinical-biological, immunophenotypical, and prognostic disease char-acteristics. Ann Hematol. 1997;75:81–86.
   Google Scholar
• Neussler V, Gieseler F, Gullis E, et al. Functional Pgp expression in multiple myeloma patients at primary diagnosis and relapse or progressive disease. Leukemia. 1997;11 (supp15):S10–514.
   Google Scholar
• Maia RC, Vasconcelos FC, Harab RC, Coelho AM, Dobbin JA, Rumjanek VM. Comparison between anthracyclines and rhodamine 123 accumulation in chronic lymphoid leukemia: effect of cyclosporin A and verapamil. Tumor Biol. 1998;19:41–51.
   Google Scholar
• Gerlach JH, Bell DR, Karakousis C. P-Glycoprotein in human sarcomas. J Chn Oncol 1987;5:1452–1460.
   Google Scholar
• Tawa A, Inoue M, Ishihara S. Increased expression of the multidrug-resistance gene in undifferenti-ated sarcoma. Cancer 1990;66:1980–1983.
   Google Scholar
• Wunder JS, Bell RS. Wold L, Andrulis IL. Expression of multidrug-resistance gene and clinical out-come in osteosarcomas. In: NovakJF, McMaster JH, eds. Frontiers of Osteosarconza Research. Seattle, WA: Hogrefe 8c Huber; 1993:71–74.
   Google Scholar
• Selak J, Hunakova L, Sulikova M, Chorvath B. Protein kinase inhibitor-induced alterations of drug uptake, cell cycle and surface antigen expression in human multidrug-resistant (Pgp and MRP) promyelocytic leukemia HL-60 cells. Leuk Res. 1997;21:449–458.
   Google Scholar
• Willman C. The prognostic significance of the expression and function of multidrug resistance trans-porter proteins in acute myeloid leukemia: studies of the Southwest Oncology Group Leukemia Research Program. Semin Hematol. 1997;34:25–33.
   PubMed Web of Science ®Google Scholar
• Laurencot CM, Scheffer GL, Scheper RJ, Shoemaker RH. Increased LRP mRNA expression is as-sociated with the MDR phenotype in intrinsically resistant human cancer cell lines. Int J Cancer. 1997;72:1021–1026.
   PubMed Web of Science ®Google Scholar